Pharmacotherapy of Type 2 Diabetes in Youth

March 20, 2019 (Noon–1:15 p.m. ET)


Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD




Type 2 diabetes is a relatively new disorder in pediatrics, leaving pediatricians with infrequent exposure and leading to limited, consensus-based management guidelines. In the last few years, however, the results of large epidemiologic and clinical trials have begun to clarify the disorder and provide an evidence base for management. In this lecture, Philip S. Zeitler, M.D., Ph.D., will review what these trials have taught us about the management of type 2 diabetes in youth, as well as the emerging treatment options. During his presentation, Dr. Zeitler will:  

  • Describe the evidence base for management of glycemic and non-glycemic aspects of type 2 diabetes in adolescents.
  • Review the various classes of medications available for treatment of type 2 diabetes in youth.
  • Understand the pros and cons of different treatment approaches for type 2 diabetes in youth

Dr. Zeitler is medical director of the Children’s Hospital Colorado Clinical Translational Research Center of the Colorado Clinical Translational Science Institute, chair of the Department of Endocrinology at Children’s Hospital Colorado, and director of the type 2 diabetes and metabolic syndrome programs.


George Giacoia, OPPTB, NICHD
Phone: 301–496–5589

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of pageBACK TO TOP